TABLE 3.
Affected pathways | POR | AMA |
Signaling pathways and signal transduction | ||
PI3K-Akt signaling pathway | † | † |
mTOR signaling pathway | † | † |
TGF-β signaling pathway | † | |
FoxO signaling pathway | † | |
Wnt signaling pathway | † | |
Hippo signaling pathway | † | |
Ras signaling pathway | † | † |
EGFR tyrosine kinase inhibitor resistance pathway | † | † |
AMPK signaling pathway | † | † |
MAPK pathway | † | † |
p53 signaling pathway | † | † |
N eurotrophins signaling pathway | † | † |
ErbB(/EGFR) signaling pathway | † | † |
JAK-STAT signaling pathway | † | † |
Cellular functions and interactions | ||
Regulation of actin cytoskeleton | † | † |
Oocyte meiosis | † | |
Apoptosis | † | |
Cellular senescence | † | † |
Mitophagy | † | |
Gap junctions | † | |
Hormonal signaling | ||
Growth hormone synthesis, secretion and action | † | † |
Protein Regulation | ||
N-glycan biosynthesis | † | † |
Glucose Metabolism | † | † |
† This symbol indicates the category of patients a certain pathway is disregulated in.